Skip to content

Veracyte VCYT Debt-to-assets

Debt-to-assets at other companies

Guardant Health logo
Guardant HealthGH
0.9×-0.1×
Natera, Inc. logo
Natera, Inc.NTRA
0.1×0.0×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
0.1×0.0×
Revvity logo
RevvityRVTY
0.3×+0.1×
Labcorp Holdings logo
Labcorp HoldingsLH
0.4×0.0×
Quest Diagnostics logo
Quest DiagnosticsDGX
0.4×0.0×

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Calculated from Veracyte’s reported figures.

Based on the most recent quarter.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's debt-to-assets?
Veracyte (VCYT) reported debt-to-assets of 0× in Q1 2026.
How has Veracyte's debt-to-assets changed year-over-year?
Veracyte's debt-to-assets decreased by 28.6% year-over-year, from 0× to 0×.
What is the long-term trend for Veracyte's debt-to-assets?
Over 5 years (2020 to 2025), Veracyte's debt-to-assets has grown at a 0.9% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.